UAE COVID vaccine trial rolls out with 5000 volunteers


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ uae-covid-vaccine-trial-news-update
UAE Coronavirus News Updates Aug 10, 2020

The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates have reached a major milestone with over 5000 volunteers who have now received their first vaccination.

The 5000th vaccination was given in the presence of Dr. Jamal Al Kaabi, the Acting Undersecretary Department of Health, Abu Dhabi, at the recently developed purpose-built walk-in registration, screening and testing centre at the Abu Dhabi National Exhibition Centre (ADNEC). Dr. Al Kaabi was the second participant in the vaccination programme and received his second shot this week.

The trials began in Abu Dhabi on 16th July and are being managed by G42 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA).

The inactivated vaccine has been developed by Sinopharm CNBG, the world’s sixth-largest vaccine manufacturer.

A sense of national pride and shared commitment has led to over 80 nationalities in the community already volunteering to participate, inspired by the UAE Leadership’s commitment to overcoming the pandemic through a global collaborative effort.

The ADNEC facility can manage 1000 volunteers a day and is open daily from 8 am to 8 pm to allow the maximum number of individuals to participate. A second walk-in centre is also now operational at the Al Qarain Health Centre in Sharjah with a daily capacity of 500.

The Ministry of Health and Prevention, MoHAP, announced Sunday that it conducted 61,544 additional COVID-19 tests over the past 24 hours, using state-of-the-art medical testing equipment. In a statement, the Ministry stressed its aim to continue expanding the scope of testing nationwide to facilitate the early detection of coronavirus cases and carry out the necessary treatment. To control the pandemic, anyone showing symptoms of COVID-19 at university in Dubai must be isolated instantly and referred for a PCR test, the newly released ‘Protocols for the Reopening of Higher Education Institutions [HEI] in Dubai’ said on Monday.

The 118-point protocol, announced by Dubai’s Knowledge and Human Development Authority (KHDA), said such a person “should not return to HEI until the result is obtained. Even if the result is negative and there is a clinical assessment of a probable COVID-19 case, the person should commence a 14-day quarantine.”

As part of its intensified testing campaign, MoHAP announced 225 new coronavirus cases, bringing the total number of cases in the UAE to 62,525. According to the Ministry, the infected individuals are from various nationalities, are in a stable condition, and are receiving the necessary care.

MoHAP also announced one death due to COVID-19 complications, bringing the total number of deaths in the country to 357.

The Ministry expressed its sincere condolences to the family of the deceased and wished current COVID-19 patients a speedy and full recovery, calling on all members of the society to cooperate with health authorities, adhere to the instructions and social distance to ensure the health and safety of all. MoHAP also noted an additional 323 individuals had fully recovered from COVID-19, bringing the total number of recoveries to 56,568.

Tags : #UAECovidNewsUpdateAug10 #Dubai #ADNECFacility #SinopharmCNBG #MoHap #AbuDhabi

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026